Extension of a Project Period Without Additional Funds:

受赠人可以将项目期限的最终预算期限延长一次，如果不需要额外的资金，则在NGA中显示的原始到期日期至12个月以外change in the project’s originally approved scope, and any one of the following applies:

• Additional time beyond the established expiration date is required to ensure adequate completion of the originally approved project.
• Continuity of NIH grant support is required while a competing continuation application is under review.
• The extension is necessary to permit an orderly phase-out of a project that will not receive continued support.

The fact that funds remain at the expiration of the grant is not, in itself, sufficient justification for an extension without additional funds.

The grantee must notify the NIH awarding office, in writing, of the extension ten days prior to the expiration date of the project period. Upon notification, the NIH awarding office will revise the project period ending date and provide an acknowledgement to the grantee. In extending the final budget period of the project period through this process, the grantee agrees to update all required certifications, including human subjects and animal welfare, in accordance with the applicable regulations and policies. Grantees may not extend project periods previously extended by the NIH awarding office. Any additional project period extension beyond the one-time extension of up to 12 months requires NIH prior approval. (See the “Prior Approval Requirements” section above.)

计划收入的使用：

The additive costs alternative for the use of program income applies to awards subject to expanded authorities unless the NGA specifies another alternative or the grantee is a for-profit organization other than an SBIR/STTR awardee. For-profit organizations other than SBIR/STTR awardees are subject to the deductive alternative. (See the NIH’s website under “Administrative Requirements – Management Systems and Procedures – Program Income.”)

Carryover of Un-obligated Balances:

Except for funds restricted in an NoA, unobligated funds remaining at the end of a budget period are automatically carried over. For awards under the Streamlined Non-Competing Award Process (SNAP), funds are automatically carried over and are available for expenditure during the entire project period. However, under those awards, the grantee will be required to indicate, as part of its non-competing continuation request, whether its estimated unobligated balance (including prior year carryover) is expected to be greater than 25% of the current year’s total budget. If so, the grantee must provide an explanation and indicate plans for expenditure of those funds if carried forward. (See the NIH’s website under “Administrative Requirements – Non-Competing Continuation Awards.”)

For those awards subject to expanded authorities but excluded from SNAP (e.g. P01s and R35s), the FSR must specify the amount to be carried over. The notification must be provided under item 12, “Remarks,” on the FSR. When a grantee reports a balance of unobligated funds in excess of 25% of the total amount awarded, the GMO will review the circumstances resulting in the balance to ensure that these funds are necessary to complete the project, and may request additional information from the grantee, including a revised budget, as part of the review. If the GMO determines that some or all of the unobligated funds are not necessary to complete the project, the GMO may take one, or a combination, of the following actions:

• Restrict the grantee’s authority to automatically carry over unobligated balances in the future.
• Use the balance to reduce or offset NIH funding for a subsequent budget period. Any amount not identified for carryover may be used as an offset. A revised NGA will not be issued to reflect the carryover.

Cost-Related Prior Approvals, including Patient Care and Equipment:

Requirements for NIH approval of incurrence of these individual costs, including rebudgeting for them, do not apply under expanded authorities unless they constitute a change in scope.

通过财团协议，合同或其他方式将实质性编程工作的绩效转移到第三方：

Under expanded authorities, a grantee is not required to obtain NIH prior approval for transferring the performance of substantive programmatic work unless the activity constitutes a change in scope or results in the transfer of substantive programmatic work to a foreign component.

REQUEST FOR APPROVAL

All requests for NIH awarding office prior approval must be made, in writing (which includes submission by email) to the designated GMO no later than 30 days before the project termination date.

Note: Send all requests to the PAF Team who will ensure it gets to the funding agency.